Home/Filings/4/0001062993-24-004576
4//SEC Filing

Talmo Paul 4

Accession 0001062993-24-004576

CIK 0001561921other

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 4:35 PM ET

Size

10.1 KB

Accession

0001062993-24-004576

Insider Transaction Report

Form 4
Period: 2024-02-23
Talmo Paul
Chief Technology Officer
Transactions
  • Award

    Common Stock

    2024-02-23+16,70072,676 total
  • Tax Payment

    Common Stock

    2024-02-23$7.07/sh2,577$18,21970,099 total
  • Tax Payment

    Common Stock

    2024-02-24$7.07/sh1,049$7,41669,050 total
  • Award

    Stock Option (Right to Buy)

    2024-02-23+24,40024,400 total
    Exercise: $7.07Exp: 2034-02-23Common Stock (24,400 underlying)
Footnotes (3)
  • [F1]These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 23, 2025, subject to the Reporting Person's continuous service through the applicable vesting dates.
  • [F2]Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs.
  • [F3]The option vests 25% on February 23, 2025, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.

Issuer

TELA Bio, Inc.

CIK 0001561921

Entity typeother

Related Parties

1
  • filerCIK 0001899089

Filing Metadata

Form type
4
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 4:35 PM ET
Size
10.1 KB